FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a method for preventing nosocomial pneumonia in cardiosurgical patients. Inhalation of nitrogen oxide in concentration of 200 ppm for 30 minutes each is carried out twice a day during first 5 days of the postoperative period.
EFFECT: invention enables reducing the number of nosocomial pneumonias in the patients operated on by cardiopulmonary bypass, and improving the results of cardiosurgical interventions.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PNEUMONIA TREATMENT IN PATIENTS WITH CARDIASURGICAL PROFILE IN EARLY POSTOPERATIVE PERIOD WITH ARTIFICIAL LUNG VENTILATION OR WITH INTUBATION | 2016 |
|
RU2638462C1 |
METHOD FOR PREVENTING VENTILATOR-ASSOCIATED PNEUMONIA | 2023 |
|
RU2821565C1 |
Respiratory therapy method for new coronavirus infection COVID-19 in patients on artificial lung ventilation | 2020 |
|
RU2744550C1 |
METHOD OF ORGAN PROTECTION IN CARDIOSURGICAL INTERVENTIONS ACCOMPANIED BY CIRCULATORY ARREST | 2019 |
|
RU2729506C1 |
METHOD FOR EARLY PREDICTION OF DEVELOPING NEONATAL PNEUMONIA IN PREMATURE INFANTS WITH EXTREMELY LOW AND VERY LOW BODY WEIGHT | 2020 |
|
RU2738577C1 |
METHOD FOR ESTIMATING POTENTIAL OF ALVEOLI RECRUITMENT WHEN CONDUCTING ARTIFICIAL VENTILATION OF LUNGS AFTER CARDIAC SURGERY | 2017 |
|
RU2645412C1 |
METHOD OF ORGANOPROTECTION IN CASE OF CARDIAC SURGERY INTERFERENCES WITH ARTIFICIAL BLOOD CIRCULATION | 2018 |
|
RU2681124C1 |
METHOD OF PROTECTING KIDNEYS DURING CONDUCTING EXTRACORPOREAL LIFE SUPPORT | 2018 |
|
RU2687010C1 |
METHOD FOR PREVENTION OF ATRIAL FIBRILLATION IN OPEN LUNG SURGERIES OF ONCOLOGY DISEASES | 2014 |
|
RU2574187C1 |
METHOD OF COGNITIVE REHABILITATION OF PATIENTS AFTER CORONARY BYPASS GRAFTING UNDER CARDIOPULMONARY BYPASS | 2022 |
|
RU2803554C1 |
Authors
Dates
2024-04-18—Published
2023-12-30—Filed